Dilaudid and Zemuron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilaudid (hydromorphone hydrochloride) and Zemuron (rocuronium bromide). Common drug interactions include enterocutaneous fistula among females and bradycardia among males.

The phase IV clinical study analyzes what interactions people have when they take Dilaudid and Zemuron. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

What is Zemuron?

Zemuron has active ingredients of rocuronium bromide. eHealthMe is studying from 873 Zemuron users. Check the latest studies of Zemuron.

On Jul, 16, 2026

63 people who take Dilaudid and Zemuron together, and have interactions are studied.

What are the common drug interactions of Dilaudid and Zemuron, by gender? *:

female:

Enterocutaneous fistula
Leukocytosis (increased white blood cells)
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
Small intestinal obstruction (blockage in small intestine)
Apnoea (suspension of external breathing)
Paralysis
Brain hypoxia (reduced supply of oxygen to the brain)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Pulmonary embolism (blockage of the main artery of the lung)
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)

male:

Bradycardia (abnormally slow heart action)
Blood creatinine increased
Bone marrow failure
Chronic kidney disease
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Cytokine storm (over-protective immune response that can actually be fatal)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematuria (presence of blood in urine)
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Hypertension (high blood pressure)

What are the common drug interactions of Dilaudid and Zemuron, by age (0-1 to 60+)? *:

0-1:

Capillary leak syndrome (capillary leaks plasma)
Hypotension (abnormally low blood pressure)

2-9:

Hypertension (high blood pressure)
Infection
Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
Diarrhoea
Diarrhoea haemorrhagic (bloody diarrhoea)
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Haematoma (collection of blood outside the blood vessels)
Pleural effusion (water on the lungs)
Pyrexia (fever)
Septic shock (shock due to blood infection)

10-19:

Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
Blood creatinine increased
Blood lactic acid increased
Blood urea increased
Bone marrow failure
Bradycardia (abnormally slow heart action)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Cytokine storm (over-protective immune response that can actually be fatal)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematuria (presence of blood in urine)

20-29:

Abdominal pain
Device dislocation
Dyspareunia (painful sexual intercourse)
Infection
Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
Pelvic pain
Uterine perforation (accidental puncture of the uterus)

30-39:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block complete (heart block complete)
Blood triglycerides increased
Bradycardia (abnormally slow heart action)
Cardiac arrest
Cardiogenic shock (inadequate circulation of blood)
Electrocardiogram qt prolonged
General physical health deterioration (weak health status)
Hepatic steatosis (fatty liver disease)
Hepatitis (inflammation of the liver)

40-49:

Anxiety
Blood creatinine increased
Bone density decreased
Cellulitis (infection under the skin)
Coma (state of unconsciousness lasting more than six hours)
Dyspnoea (difficult or laboured respiration)
Exposed bone in jaw
Groin abscess (pus in groin)
Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs)
Hip arthroplasty

50-59:

Cellulitis (infection under the skin)
Gas gangrene (bacterial infection that produces gas within tissues)
Groin abscess (pus in groin)
Groin pain
Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
Scrotal cyst (cyst of scrotum)
Scrotal pain
Scrotal swelling
Testicular pain (pain in testes)
Acute circulatory failure (shock)

60+:

Leukocytosis (increased white blood cells)
Abdominal infection
Post procedural complication
Post procedural haemorrhage (post procedural bleeding)
Psychotic disorder
Respiratory depression (respiration has a rate below 12 breaths)
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
Drug resistance (reduction in effectiveness of a drug)
Acute hepatic failure
Acute respiratory failure

What are the existing conditions these people have? *

Hypotension (abnormally low blood pressure): 12 people, 19.05%
High Blood Pressure: 11 people, 17.46%
Constipation: 9 people, 14.29%
Nausea (feeling of having an urge to vomit): 9 people, 14.29%
Type 2 Diabetes: 7 people, 11.11%
Depression: 7 people, 11.11%
Stress And Anxiety: 6 people, 9.52%
Anaesthesia: 6 people, 9.52%
Nausea And Vomiting: 5 people, 7.94%
Cardiac Disorder: 5 people, 7.94%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and Zemuron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously